Literature DB >> 10051622

In situ detection of activated Bruton's tyrosine kinase in the Ig signaling complex by phosphopeptide-specific monoclonal antibodies.

S Nisitani1, R M Kato, D J Rawlings, O N Witte, M I Wahl.   

Abstract

Bruton's tyrosine kinase (Btk) is a critical transducer of signals originating from the B cell antigen receptor (BCR). Dosage, sequential phosphorylation, and protein interactions are interdependent mechanisms influencing Btk function. Phosphopeptide-specific mAbs recognizing two distinct phosphotyrosine modifications were used to quantify Btk activation by immunofluorescent techniques during B cell stimulation. In a population of cultured B cells stimulated by BCR crosslinking and analyzed by flow cytometry, transient phosphorylation of the regulatory Btk tyrosine residues (551Y and 223Y) was detected. The kinetics of phosphorylation of the residues were temporally distinct. Tyrosine 551, a transactivating substrate site for Src-family kinases, was maximally phosphorylated within approximately 30 seconds of stimulation as monitored by flow cytometry. Tyrosine 223, an autophosphorylation site within the SH3 domain, was maximally phosphorylated at approximately 5 minutes. Btk returned to a low tyrosine phosphorylation level within 30 minutes, despite persistent elevation of global tyrosine phosphorylation. Colocalization of activated Btk molecules with the crosslinked BCR signaling complex was observed to coincide with the period of maximal Btk tyrosine phosphorylation when stimulated B cells were analyzed with confocal microscopy. The results of these in situ temporal and spatial analyses imply that Btk signaling occurs in the region of the Ig receptor signaling complex, suggesting a similar location for downstream targets of its activity.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10051622      PMCID: PMC26764          DOI: 10.1073/pnas.96.5.2221

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  40 in total

1.  Severe B cell deficiency and disrupted splenic architecture in transgenic mice expressing the E41K mutated form of Bruton's tyrosine kinase.

Authors:  G M Dingjan; A Maas; M C Nawijn; L Smit; J S Voerman; F Grosveld; R W Hendriks
Journal:  EMBO J       Date:  1998-09-15       Impact factor: 11.598

Review 2.  Molecular mechanisms in B cell antigen receptor signaling.

Authors:  T Kurosaki
Journal:  Curr Opin Immunol       Date:  1997-06       Impact factor: 7.486

3.  Activation of BTK by a phosphorylation mechanism initiated by SRC family kinases.

Authors:  D J Rawlings; A M Scharenberg; H Park; M I Wahl; S Lin; R M Kato; A C Fluckiger; O N Witte; J P Kinet
Journal:  Science       Date:  1996-02-09       Impact factor: 47.728

4.  Wortmannin, a potent and selective inhibitor of phosphatidylinositol-3-kinase.

Authors:  G Powis; R Bonjouklian; M M Berggren; A Gallegos; R Abraham; C Ashendel; L Zalkow; W F Matter; J Dodge; G Grindey
Journal:  Cancer Res       Date:  1994-05-01       Impact factor: 12.701

5.  A role for Bruton's tyrosine kinase (Btk) in platelet activation by collagen.

Authors:  L S Quek; J Bolen; S P Watson
Journal:  Curr Biol       Date:  1998-10-08       Impact factor: 10.834

6.  CD38 unresponsiveness of xid B cells implicates Bruton's tyrosine kinase (btk) as a regular of CD38 induced signal transduction.

Authors:  L Santos-Argumedo; F E Lund; A W Heath; N Solvason; W W Wu; J C Grimaldi; R M Parkhouse; M Howard
Journal:  Int Immunol       Date:  1995-02       Impact factor: 4.823

7.  SRC64 regulates the localization of a Tec-family kinase required for Drosophila ring canal growth.

Authors:  D J Guarnieri; G S Dodson; M A Simon
Journal:  Mol Cell       Date:  1998-05       Impact factor: 17.970

8.  Src family protein tyrosine kinases induce autoactivation of Bruton's tyrosine kinase.

Authors:  S Mahajan; J Fargnoli; A L Burkhardt; S A Kut; S J Saouaf; J B Bolen
Journal:  Mol Cell Biol       Date:  1995-10       Impact factor: 4.272

9.  Independent and opposing roles for Btk and lyn in B and myeloid signaling pathways.

Authors:  A B Satterthwaite; C A Lowell; W N Khan; P Sideras; F W Alt; O N Witte
Journal:  J Exp Med       Date:  1998-09-07       Impact factor: 14.307

10.  A role for Bruton's tyrosine kinase in B cell antigen receptor-mediated activation of phospholipase C-gamma 2.

Authors:  M Takata; T Kurosaki
Journal:  J Exp Med       Date:  1996-07-01       Impact factor: 14.307

View more
  14 in total

1.  Posttranscriptional regulation of Bruton's tyrosine kinase expression in antigen receptor-stimulated splenic B cells.

Authors:  S Nisitani; A B Satterthwaite; K Akashi; I L Weissman; O N Witte; M I Wahl
Journal:  Proc Natl Acad Sci U S A       Date:  2000-03-14       Impact factor: 11.205

2.  Competing modes of self-association in the regulatory domains of Bruton's tyrosine kinase: intramolecular contact versus asymmetric homodimerization.

Authors:  Alain Laederach; Kendall W Cradic; Kristine N Brazin; Jamillah Zamoon; D Bruce Fulton; Xin-Yun Huang; Amy H Andreotti
Journal:  Protein Sci       Date:  2002-01       Impact factor: 6.725

3.  PKCbeta modulates antigen receptor signaling via regulation of Btk membrane localization.

Authors:  S W Kang; M I Wahl; J Chu; J Kitaura; Y Kawakami; R M Kato; R Tabuchi; A Tarakhovsky; T Kawakami; C W Turck; O N Witte; D J Rawlings
Journal:  EMBO J       Date:  2001-10-15       Impact factor: 11.598

4.  Structural insights into the tyrosine phosphorylation-mediated inhibition of SH3 domain-ligand interactions.

Authors:  Balázs Merő; László Radnai; Gergő Gógl; Orsolya Tőke; Ibolya Leveles; Kitti Koprivanacz; Bálint Szeder; Metta Dülk; Gyöngyi Kudlik; Virág Vas; Anna Cserkaszky; Szabolcs Sipeki; László Nyitray; Beáta G Vértessy; László Buday
Journal:  J Biol Chem       Date:  2019-01-18       Impact factor: 5.157

5.  Regulation of oxidative stress-induced calcium release by phosphatidylinositol 3-kinase and Bruton's tyrosine kinase in B cells.

Authors:  S Qin; E R Stadtman; P B Chock
Journal:  Proc Natl Acad Sci U S A       Date:  2000-06-20       Impact factor: 11.205

6.  Assaying Bcr-Abl kinase activity and inhibition in whole cell extracts by phosphorylation of substrates immobilized on agarose beads.

Authors:  Ding Wu; Evan Nair-Gill; Dorie A Sher; Laurie L Parker; Jennifer M Campbell; Mariah Siddiqui; Wendy Stock; Stephen J Kron
Journal:  Anal Biochem       Date:  2005-09-22       Impact factor: 3.365

7.  Quantitative immunofluorescence reveals the signature of active B-cell receptor signaling in diffuse large B-cell lymphoma.

Authors:  Agata M Bogusz; Richard H G Baxter; Treeve Currie; Papiya Sinha; Aliyah R Sohani; Jeffery L Kutok; Scott J Rodig
Journal:  Clin Cancer Res       Date:  2012-09-10       Impact factor: 12.531

8.  Naturally occurring Bruton's tyrosine kinase mutations have no dominant negative effect in an X-linked agammaglobulinaemia cellular model.

Authors:  R Pérez de Diego; E López-Granados; J Rivera; A Ferreira; G Fontán; J Bravo; M C García Rodríguez; S Bolland
Journal:  Clin Exp Immunol       Date:  2008-01-28       Impact factor: 4.330

9.  Flow cytometric assessment of the signaling status of human B lymphocytes from normal and autoimmune individuals.

Authors:  Amrie C Grammer; Randy Fischer; Olivia Lee; Xuan Zhang; Peter E Lipsky
Journal:  Arthritis Res Ther       Date:  2004-02-05       Impact factor: 5.156

10.  A crucial role for the p110delta subunit of phosphatidylinositol 3-kinase in B cell development and activation.

Authors:  Elizabeth Clayton; Giuseppe Bardi; Sarah E Bell; David Chantry; C Peter Downes; Alexander Gray; Lisa A Humphries; David Rawlings; Helen Reynolds; Elena Vigorito; Martin Turner
Journal:  J Exp Med       Date:  2002-09-16       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.